Brief: Strategic partner Intega Skin Sciences Inc,acquired by Crescita Therapeutics Inc

Crescita Therapeutics

01/09/2016 14:25

Sept 1 (Reuters) - Knight Therapeutics Inc  
    * As part of Crescita acquisition, it was agreed that $3.0 
million of Knight's secured loan will be repaid 
    * As part of Crescita deal , it was agreed that interest 
rate on Knight's  remaining loan balance will be reduced to 
9%/year 
    * Received 645,002 common shares of Crescita in exchange for 
its intega shares 
    * Now owns an aggregate of 1.5 million common shares of 
crescita, representing about 10.9% of outstanding common shares 
of Crescita 
    * Strategic partner Intega Skin Sciences Inc, a 
Montreal-based Dermatology Company, has been acquired by 
Crescita Therapeutics Inc 
 
Source text for Eikon:  ID:nCCN8QF7qj  
 
 ((Bangalore.newsroom@thomsonreuters.com;))